Jane Street Group, LLC Protalix Bio Therapeutics, Inc. Transaction History

Jane Street Group, LLC

$88.2 Billion
Q2 2024

A detailed history of Jane Street Group, LLC transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 290,259 shares of PLX stock, worth $380,239. This represents 0.0% of its overall portfolio holdings.

Number of Shares

290,259

Previous 28,921 903.63%

Holding current value

$380,239

Previous $36,000 841.67%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.1 - $1.32 $287,471 - $344,966	261,338 Added 903.63%	290,259 $339,000
Q1 2024 May 15, 2024	BUY	$1.22 - $1.82 $117 - $174	96 Added 0.33%	28,921 $36,000
Q4 2023 Feb 14, 2024	BUY	$1.34 - $1.85 $38,625 - $53,326	28,825 New	28,825 $51,000
Q2 2023 Aug 14, 2023	BUY	$2.0 - $3.36 $472,834 - $794,361	236,417 Added 596.03%	276,082 $552,000
Q1 2023 May 15, 2023	SELL	$1.37 - $2.16 $71,998 - $113,516	-52,554 Reduced 56.99%	39,665 $83,000
Q4 2022 Feb 14, 2023	BUY	$1.0 - $1.37 $13,743 - $18,827	13,743 Added 17.51%	92,219 $126,000
Q3 2022 Nov 14, 2022	SELL	$1.03 - $1.24 $5,232 - $6,299	-5,080 Reduced 6.08%	78,476 $82,000
Q2 2022 Aug 16, 2022	SELL	$1.02 - $1.56 $62,885 - $96,177	-61,652 Reduced 42.46%	83,556 $91,000
Q1 2022 May 17, 2022	BUY	$0.81 - $1.17 $48,235 - $69,673	59,550 Added 69.52%	145,208 $154,000
Q4 2021 Feb 15, 2022	BUY	$0.81 - $1.33 $36,214 - $59,462	44,709 Added 109.18%	85,658 $71,000
Q3 2021 Nov 16, 2021	BUY	$1.31 - $1.87 $12,162 - $17,361	9,284 Added 29.32%	40,949 $54,000
Q2 2021 Aug 16, 2021	SELL	$1.86 - $6.22 $30,993 - $103,643	-16,663 Reduced 34.48%	31,665 $60,000
Q1 2021 May 18, 2021	BUY	$3.58 - $6.45 $93,473 - $168,409	26,110 Added 117.52%	48,328 $215,000
Q4 2020 Feb 17, 2021	BUY	$3.15 - $3.98 $23,804 - $30,076	7,557 Added 51.54%	22,218 $81,000
Q3 2020 Nov 17, 2020	SELL	$3.37 - $3.93 $435,269 - $507,598	-129,160 Reduced 89.81%	14,661 $57,000
Q2 2020 Aug 17, 2020	BUY	$2.19 - $4.5 $204,697 - $420,610	93,469 Added 185.63%	143,821 $542,000
Q1 2020 May 15, 2020	BUY	$2.1 - $4.61 $36,808 - $80,804	17,528 Added 53.4%	50,352 $124,000
Q4 2019 Feb 14, 2020	BUY	$1.8 - $3.28 $59,083 - $107,662	32,824 New	32,824 $105,000

Others Institutions Holding PLX

# of Institutions

Shares Held

3.9M

Call Options Held

61.1K

Put Options Held

36.2K

View Full List

About Protalix BioTherapeutics, Inc.

Ticker PLX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,753,400
Market Cap $65.2M
Description
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...

More about PLX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Protalix Bio Therapeutics, Inc. Transaction History